爱科集团

Agco: JP Morgan raises PT to $138 from $123, maintains Overweight rating.

Agco's 15min chart shows RSI overbought, Bollinger Bands narrowing, KDJ death cross.

Agco's 15min chart triggers RSI overbought, Bollinger Bands narrowing.

AGCO Triggers MACD Death Cross, RSI Overbought on 15-Minute Chart

Catalyst<ul> <li>Multiple bullish candlestick patterns including Bullish Engulfing, Bearish Engulfing, and Marubozu White in late January and early February indicate strong upward momentum for AGCO.</li></ul>Risk<ul> <li>Technical indicators show mixed signals with one MACD Golden Cross indicating a bearish bias, suggesting potential downward pressure.</li> <li>Analyst ratings remain neutral with no consensus, reflecting uncertainty about the stock's future direction.</li> <li>Fund flows show a negative overall trend, with small and extra-large orders contributing to outflows, which may pressure the stock's performance.</li></ul>

Key Factors

AGCO reported Q4 2025 net sales of $2.9 billion, exceeding estimates and marking a 1.1% year-over-year increase. AGCO generated record free cash flow of $740 million for the full year 2025, despite a 13.5% decline in annual net sales to $10.1 billion. AGCO announced a 2026 sales target of $10.4 billion to $10.7 billion, focusing on precision agriculture advancements and cost savings. AGCO's stock reached a 21-month high after Q4 revenue beat expectations and the company provided an optimistic outlook for 2026. JP Morgan raised AGCO's price target to $138 from $123, maintaining an Overweight rating based on its positive outlook for the company.

AGCO News